The CD47 pathway is deregulated in human immune thrombocytopenia

Lucia Catani, Daria Sollazzo, Francesca Ricci, Nicola Polverelli, Francesca Palandri, Michele Baccarani, Nicola Vianelli, Roberto M. Lemoli

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: A novel mechanism of platelet destruction involving the CD47/ signal regulatory protein-α (SIRPα) system has recently been suggested in a mouse model of immune thrombocytopenia (ITP). The CD47 molecule serves as ligand for SIRPα receptor and as receptor for thrombospondin acting as antagonistic to phagocyte activity and a regulator of apoptosis, respectively. In this study, we evaluated if the CD47/SIRPα axis may be involved in the apoptosis and clearance of platelets in human ITP. Materials and Methods: Using flow cytometry, we characterized whether expression of CD47 on fresh and in vitro-aged platelets- and of SIRPα receptor on CD14-derived dendritic cells (DCs), macrophages, circulating DCs, and monocytes is reduced is ITP; whether the in vitro platelet phagocytic capacity of CD14-derived DCs and macrophages is differentially modulated in the presence or absence of antibodies against CD47 and SIRPα in ITP; and whether platelets are more susceptible to the CD47-induced death signal in ITP. Results: We demonstrated that low platelet count in ITP is not due to increased phagocytosis associated with decreased expression of CD47 on the platelet surface and, despite reduced SIRPα expression, blockage of SIRPα on immature CD14-derived DCs or CD47 on platelets by specific antibodies failed to modify platelet uptake/phagocytosis of DCs. In contrast, targeting platelet CD47 with specific antibody significantly increases platelet phagocytosis of CD14-derived macrophages, and platelets are not healthy because they show increased apoptosis and are resistant to CD47-induced death signal. Conclusions: Our results demonstrate that the CD47 pathway in ITP patients abnormally modulates platelet homeostasis.

Original languageEnglish
Pages (from-to)486-494
Number of pages9
JournalExperimental Hematology
Volume39
Issue number4
DOIs
Publication statusPublished - Apr 2011

Fingerprint

Idiopathic Thrombocytopenic Purpura
Blood Platelets
Dendritic Cells
Phagocytosis
Proteins
Macrophages
Apoptosis
Antibodies
CD36 Antigens
Phagocytes
Platelet Count
Monocytes
Flow Cytometry
Homeostasis

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Molecular Biology
  • Hematology

Cite this

Catani, L., Sollazzo, D., Ricci, F., Polverelli, N., Palandri, F., Baccarani, M., ... Lemoli, R. M. (2011). The CD47 pathway is deregulated in human immune thrombocytopenia. Experimental Hematology, 39(4), 486-494. https://doi.org/10.1016/j.exphem.2010.12.011

The CD47 pathway is deregulated in human immune thrombocytopenia. / Catani, Lucia; Sollazzo, Daria; Ricci, Francesca; Polverelli, Nicola; Palandri, Francesca; Baccarani, Michele; Vianelli, Nicola; Lemoli, Roberto M.

In: Experimental Hematology, Vol. 39, No. 4, 04.2011, p. 486-494.

Research output: Contribution to journalArticle

Catani, L, Sollazzo, D, Ricci, F, Polverelli, N, Palandri, F, Baccarani, M, Vianelli, N & Lemoli, RM 2011, 'The CD47 pathway is deregulated in human immune thrombocytopenia', Experimental Hematology, vol. 39, no. 4, pp. 486-494. https://doi.org/10.1016/j.exphem.2010.12.011
Catani L, Sollazzo D, Ricci F, Polverelli N, Palandri F, Baccarani M et al. The CD47 pathway is deregulated in human immune thrombocytopenia. Experimental Hematology. 2011 Apr;39(4):486-494. https://doi.org/10.1016/j.exphem.2010.12.011
Catani, Lucia ; Sollazzo, Daria ; Ricci, Francesca ; Polverelli, Nicola ; Palandri, Francesca ; Baccarani, Michele ; Vianelli, Nicola ; Lemoli, Roberto M. / The CD47 pathway is deregulated in human immune thrombocytopenia. In: Experimental Hematology. 2011 ; Vol. 39, No. 4. pp. 486-494.
@article{8c0498697a8e48498d8c49399fe9ccc9,
title = "The CD47 pathway is deregulated in human immune thrombocytopenia",
abstract = "Objective: A novel mechanism of platelet destruction involving the CD47/ signal regulatory protein-α (SIRPα) system has recently been suggested in a mouse model of immune thrombocytopenia (ITP). The CD47 molecule serves as ligand for SIRPα receptor and as receptor for thrombospondin acting as antagonistic to phagocyte activity and a regulator of apoptosis, respectively. In this study, we evaluated if the CD47/SIRPα axis may be involved in the apoptosis and clearance of platelets in human ITP. Materials and Methods: Using flow cytometry, we characterized whether expression of CD47 on fresh and in vitro-aged platelets- and of SIRPα receptor on CD14-derived dendritic cells (DCs), macrophages, circulating DCs, and monocytes is reduced is ITP; whether the in vitro platelet phagocytic capacity of CD14-derived DCs and macrophages is differentially modulated in the presence or absence of antibodies against CD47 and SIRPα in ITP; and whether platelets are more susceptible to the CD47-induced death signal in ITP. Results: We demonstrated that low platelet count in ITP is not due to increased phagocytosis associated with decreased expression of CD47 on the platelet surface and, despite reduced SIRPα expression, blockage of SIRPα on immature CD14-derived DCs or CD47 on platelets by specific antibodies failed to modify platelet uptake/phagocytosis of DCs. In contrast, targeting platelet CD47 with specific antibody significantly increases platelet phagocytosis of CD14-derived macrophages, and platelets are not healthy because they show increased apoptosis and are resistant to CD47-induced death signal. Conclusions: Our results demonstrate that the CD47 pathway in ITP patients abnormally modulates platelet homeostasis.",
author = "Lucia Catani and Daria Sollazzo and Francesca Ricci and Nicola Polverelli and Francesca Palandri and Michele Baccarani and Nicola Vianelli and Lemoli, {Roberto M.}",
year = "2011",
month = "4",
doi = "10.1016/j.exphem.2010.12.011",
language = "English",
volume = "39",
pages = "486--494",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - The CD47 pathway is deregulated in human immune thrombocytopenia

AU - Catani, Lucia

AU - Sollazzo, Daria

AU - Ricci, Francesca

AU - Polverelli, Nicola

AU - Palandri, Francesca

AU - Baccarani, Michele

AU - Vianelli, Nicola

AU - Lemoli, Roberto M.

PY - 2011/4

Y1 - 2011/4

N2 - Objective: A novel mechanism of platelet destruction involving the CD47/ signal regulatory protein-α (SIRPα) system has recently been suggested in a mouse model of immune thrombocytopenia (ITP). The CD47 molecule serves as ligand for SIRPα receptor and as receptor for thrombospondin acting as antagonistic to phagocyte activity and a regulator of apoptosis, respectively. In this study, we evaluated if the CD47/SIRPα axis may be involved in the apoptosis and clearance of platelets in human ITP. Materials and Methods: Using flow cytometry, we characterized whether expression of CD47 on fresh and in vitro-aged platelets- and of SIRPα receptor on CD14-derived dendritic cells (DCs), macrophages, circulating DCs, and monocytes is reduced is ITP; whether the in vitro platelet phagocytic capacity of CD14-derived DCs and macrophages is differentially modulated in the presence or absence of antibodies against CD47 and SIRPα in ITP; and whether platelets are more susceptible to the CD47-induced death signal in ITP. Results: We demonstrated that low platelet count in ITP is not due to increased phagocytosis associated with decreased expression of CD47 on the platelet surface and, despite reduced SIRPα expression, blockage of SIRPα on immature CD14-derived DCs or CD47 on platelets by specific antibodies failed to modify platelet uptake/phagocytosis of DCs. In contrast, targeting platelet CD47 with specific antibody significantly increases platelet phagocytosis of CD14-derived macrophages, and platelets are not healthy because they show increased apoptosis and are resistant to CD47-induced death signal. Conclusions: Our results demonstrate that the CD47 pathway in ITP patients abnormally modulates platelet homeostasis.

AB - Objective: A novel mechanism of platelet destruction involving the CD47/ signal regulatory protein-α (SIRPα) system has recently been suggested in a mouse model of immune thrombocytopenia (ITP). The CD47 molecule serves as ligand for SIRPα receptor and as receptor for thrombospondin acting as antagonistic to phagocyte activity and a regulator of apoptosis, respectively. In this study, we evaluated if the CD47/SIRPα axis may be involved in the apoptosis and clearance of platelets in human ITP. Materials and Methods: Using flow cytometry, we characterized whether expression of CD47 on fresh and in vitro-aged platelets- and of SIRPα receptor on CD14-derived dendritic cells (DCs), macrophages, circulating DCs, and monocytes is reduced is ITP; whether the in vitro platelet phagocytic capacity of CD14-derived DCs and macrophages is differentially modulated in the presence or absence of antibodies against CD47 and SIRPα in ITP; and whether platelets are more susceptible to the CD47-induced death signal in ITP. Results: We demonstrated that low platelet count in ITP is not due to increased phagocytosis associated with decreased expression of CD47 on the platelet surface and, despite reduced SIRPα expression, blockage of SIRPα on immature CD14-derived DCs or CD47 on platelets by specific antibodies failed to modify platelet uptake/phagocytosis of DCs. In contrast, targeting platelet CD47 with specific antibody significantly increases platelet phagocytosis of CD14-derived macrophages, and platelets are not healthy because they show increased apoptosis and are resistant to CD47-induced death signal. Conclusions: Our results demonstrate that the CD47 pathway in ITP patients abnormally modulates platelet homeostasis.

UR - http://www.scopus.com/inward/record.url?scp=79952695582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952695582&partnerID=8YFLogxK

U2 - 10.1016/j.exphem.2010.12.011

DO - 10.1016/j.exphem.2010.12.011

M3 - Article

C2 - 21211546

AN - SCOPUS:79952695582

VL - 39

SP - 486

EP - 494

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 4

ER -